These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30656820)

  • 21. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.
    Moore RA; Derry S; McQuay HJ
    BMC Musculoskelet Disord; 2007 Aug; 8():73. PubMed ID: 17683540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs.
    Thomas D; Ali Z; Zachariah S; Sundararaj KGS; Van Cuyk M; Cooper JC
    Am J Cardiovasc Drugs; 2017 Oct; 17(5):343-346. PubMed ID: 28353025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials.
    Dentali F; Douketis JD; Lim W; Crowther M
    Arch Intern Med; 2007 Jan; 167(2):117-24. PubMed ID: 17242311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
    Rostom A; Dubé C; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
    Ann Intern Med; 2007 Mar; 146(5):376-89. PubMed ID: 17339623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to advise aspirin use in patients who need NSAIDs.
    Sopena F; Lanas A
    Curr Pharm Des; 2007; 13(22):2248-60. PubMed ID: 17691998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.
    Greenberg JD; Bingham CO; Abramson SB; Reed G; Sebaldt RJ; Kremer J
    Arthritis Rheum; 2005 Feb; 53(1):12-7. PubMed ID: 15696570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand V
    Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
    Jaturapatporn D; Isaac MG; McCleery J; Tabet N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analgesics, NSAIDS, and coxibs in rheumatic pain].
    Di Matteo L
    Reumatismo; 2006; 58 Spec No.1():84-9. PubMed ID: 23631071
    [No Abstract]   [Full Text] [Related]  

  • 31. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC; Kania J; Burnat G; Hahn EG
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
    Yang C; Qian J; Tang X; Gao P; Hu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials.
    Chen LC; Ashcroft DM
    J Clin Pharm Ther; 2006 Dec; 31(6):565-76. PubMed ID: 17176361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials.
    Zhang J; Ding EL; Song Y
    JAMA; 2006 Oct; 296(13):1619-32. PubMed ID: 16968832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can We Select Patients for Colorectal Cancer Prevention with Aspirin?
    Kraus S; Sion D; Arber N
    Curr Pharm Des; 2015; 21(35):5127-34. PubMed ID: 26369678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials.
    Ranpura V; Hapani S; Chuang J; Wu S
    Acta Oncol; 2010 Apr; 49(3):287-97. PubMed ID: 20156114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E
    Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin for Primary Prevention of Cardiovascular Events.
    Abdelaziz HK; Saad M; Pothineni NVK; Megaly M; Potluri R; Saleh M; Kon DLC; Roberts DH; Bhatt DL; Aronow HD; Abbott JD; Mehta JL
    J Am Coll Cardiol; 2019 Jun; 73(23):2915-2929. PubMed ID: 31196447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal safety of coxibs: systematic review and meta-analysis of observational studies on selective inhibitors of cyclo-oxygenase 2.
    Martín Arias LH; Martín González A; Sanz Fadrique R; Salgueiro Vázquez E
    Fundam Clin Pharmacol; 2019 Apr; 33(2):134-147. PubMed ID: 30383903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.
    Bonovas S; Fiorino G; Lytras T; Malesci A; Danese S
    World J Gastroenterol; 2016 May; 22(18):4594-603. PubMed ID: 27182169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.